Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis

Background: Diagnostic performance of PET/CT using 18F-fluciclovine (18F-FACBC) in patients with prostate cancer (PCa) has been evaluated in only a few studies. There is no consensus on the diagnostic value of 18F-FACBC PET/CT in PCa recurrence or metastasis (except for bone metastasis), the primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Bin, Xu, Yong, Shan, Kong, Qing-Fang, Zhao, Sun, Zhang, Guang-Yuan, Wu, Jian-Ping, Chen, Shu-Qiu, Zhu, Wei-Dong, Pan, Ke-Hao, Du, Mu-Long, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965050/
https://www.ncbi.nlm.nih.gov/pubmed/31998634
http://dx.doi.org/10.3389/fonc.2019.01438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965050/
https://www.ncbi.nlm.nih.gov/pubmed/31998634
http://dx.doi.org/10.3389/fonc.2019.01438

Ejemplares similares